Therefore, the aim of this study was to evaluate the effect of the gut microbiota-DAP-NOD1/RIP2 signaling axis on the progression of AP as well as the intervention mechanism of QYKL and neomycin. The gene discussed is RIPK2; the disease is alkaline phosphatase measurement.